The People's Vaccine: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19

Rimmer, Matthew

doi:10.2139/ssrn.3914440

Cited by 2 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study's insights are in line with Kampmark (2022) and Sekalala et al (2021), who critique the monopolistic control over vaccine production and distribution enabled by IP rights (Kampmark, 2022;Sekalala et al, 2021). These critiques resonate with our findings, which suggest that the waiver of IP rights, as proposed in the context of "The People's Vaccine" (Rimmer, 2021), could facilitate more equitable access to COVID-19 vaccines. This supports the notion that in times of global health emergencies, there is a moral and ethical imperative to prioritize public health over IP protections.…”

Section: Discussionsupporting

confidence: 83%

“…Their analysis points to the urgent need for a reevaluation of IP norms and practices to address the inherent inequalities in global health access (Sekalala et al, 2021). Rimmer (2021) offers a perspective on the potential for IP law reform in the wake of the COVID-19 pandemic, advocating for "The People's Vaccine"-a concept rooted in the idea of a globally accessible vaccine developed and distributed without the constraints of traditional IP protections. This notion challenges the prevailing IP regime, suggesting an alternative model that prioritizes public health over profit motives, reflecting a growing consensus on the need for more equitable approaches to IP and health (Rimmer, 2021).…”

Section: Introductionmentioning

confidence: 99%

“…Rimmer (2021) offers a perspective on the potential for IP law reform in the wake of the COVID-19 pandemic, advocating for "The People's Vaccine"-a concept rooted in the idea of a globally accessible vaccine developed and distributed without the constraints of traditional IP protections. This notion challenges the prevailing IP regime, suggesting an alternative model that prioritizes public health over profit motives, reflecting a growing consensus on the need for more equitable approaches to IP and health (Rimmer, 2021). Finally, Motari (2021) examines the role of IP rights on access to medicines in the WHO African Region, 25 years after the TRIPS agreement.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Access to Medicines and Intellectual Property Law: Balancing Innovation and Public Health

Rauf,

Tamang

2023

ISSLP

View full text Add to dashboard Cite

This article aims to explore the relationship between trade law and environmental policy, delving into the conflicts and synergies that arise at this intersection. Through a comprehensive literature review, this study illuminates the challenges and opportunities presented by the integration of trade regulations and environmental protections, with the aim of contributing to the ongoing dialogue on sustainable development. The analysis is structured around key themes, including trade barriers posed by environmental regulations, disputes within the World Trade Organization (WTO) and other forums, and the tension between economic growth and environmental sustainability. Additionally, the article highlights the potential for trade to serve as a vehicle for environmental goods and services, the role of environmental exceptions in trade agreements, and the importance of collaborative frameworks in reconciling trade and environmental objectives. Drawing on a range of case studies, the review provides insights into specific instances where trade law and environmental policy have intersected, revealing both challenges and pathways to synergy. Based on the findings, a set of policy recommendations is proposed, aimed at enhancing policy coherence, promoting international cooperation, and supporting the transition to a green economy. The conclusion underscores the importance of a multifaceted approach that balances economic, environmental, and social objectives, advocating for a global trading system that supports environmental protection and promotes long-term sustainable development. This article contributes to the broader understanding of how trade law can be aligned with environmental policy to achieve common goals, highlighting the critical need for innovation, collaboration, and commitment to sustainable development principles in the face of global environmental challenges.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Access to Medicines and Intellectual Property Law: Balancing Innovation and Public Health

Rauf,

Tamang

2023

ISSLP

View full text Add to dashboard Cite

show abstract

“…They argued that suspending the IP rights of COVID-19 vaccines will dissuade pharmaceutical companies to pursue their efforts in terms of research and development. The European Union (hereinafter "EU"), Germany, Japan and Switzerland were examples of opponents to this idea [32]. Some authors also consider that suspending IP rights should not be encouraged, they believe that pharmaceutical companies are already cooperating and giving access to their vaccines [33].…”

Section: Limitations Of the Existing Mechanisms Implemented To Tackle...mentioning

confidence: 99%

Access to COVID-19 Vaccines: A New Global Approach

Bouderhem

2022

Vaccines

View full text Add to dashboard Cite

This paper addresses the legal aspects and unprecedented consequences of the Coronavirus disease 2019 (COVID-19) pandemic on the manufacturing and fair access to vaccines. A research literature review allowed us to identify and evaluate the weaknesses of international health law to combat global health crises such as the COVID-19 pandemic. A new paradigm must encourage World Health Organization (WHO) and World Trade Organization (WTO) members to explicitly consider vaccines as global public goods and adopt a new set of legally binding rules for a fair and unrestricted access in times of pandemic. Initiatives and mechanisms such as COVID-19 Vaccine Global Access Facility (COVAX) have been developed to tackle the pandemic and allow developing countries to access vaccines but most were limited and never reached the expected results. The key role played by the WHO in global health policy needs to be strengthened throughout the revision of the International Health Regulations (IHR). Globalization and health are interconnected: WTO members shall revise the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and grant permanent intellectual property (IP) waivers on vaccines in times of pandemic. Our postulation is that vaccines constitute global public goods; their manufacturing and access must be facilitated and guaranteed by specific rules and mechanisms under the supervision of both the WHO and the WTO. It is, therefore, essential to provide the WHO with new powers and attributions to impose coordinated health policies to combat diseases and global crises such as the COVID-19 pandemic.

show abstract

The People's Vaccine: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19

Abstract: This paper explores intellectual property and access to essential medicines in the context of the coronavirus COVID-19 public health crisis. It considers policy solutions to counteract vaccine nationalism and profiteering *

Cited by 2 publications

References 7 publications

Access to Medicines and Intellectual Property Law: Balancing Innovation and Public Health

Access to Medicines and Intellectual Property Law: Balancing Innovation and Public Health

Access to COVID-19 Vaccines: A New Global Approach

Contact Info

Product

Resources

About